A new study compares CPZ and LPC models, creating a genetic roadmap to accelerate myelin regeneration therapies for Multiple Sclerosis.
Get the latest international news and world events from around the world.
The “impossible” LED that could change everything
Scientists at the University of Cambridge have achieved what was once considered impossible by electrically powering insulating nanoparticles to create a completely new kind of LED. Using tiny organic “molecular antennas,” the team found a way to funnel energy into materials that normally cannot conduct electricity, producing ultra pure near infrared light with remarkable efficiency.
Schrödinger’s clock: Time could tick faster and slower at the same time
Time might be even stranger than Einstein imagined. Physicists are now exploring the possibility that a single clock could exist in a quantum superposition, ticking both faster and slower at the same time — almost like Schrödinger’s cat being both alive and dead simultaneously. Using incredibly precise atomic clocks and cutting-edge quantum technologies, researchers believe they may soon be able to test this bizarre prediction in the lab for the first time.
Tailored drinks could provide space nutrition
Researchers have developed customizable omega-3 nanoemulsion drinks to protect astronauts’ bones and muscles from space radiation. [ https://www.labroots.com/trending/space/30563/tailored-drink…utrition-2](https://www.labroots.com/trending/space/30563/tailored-drink…utrition-2)
How could customizable drinks help provide astronauts on future, long-term space missions with the proper levels of nutrition? This is what a recent study published in ACS Food Science & Technology hopes to address as a team of researchers investigated novel methods for improving future astronaut diets. This study has the potential to help scientists, mission planners, and astronauts develop improved dietary plans, specifically as space mission durations are aimed to increase in the coming years.
For the study, the researchers introduced beverage nanoemulsion drinks, with emulsion drinks being a common drink that typically consists of a blended mixture of two normally non-mixable substances like an oily substance and watery substance with microscopic droplets within the liquid since they don’t full mix together. In this case, the researchers propose nanoemulsion drinks with even smaller droplets and consist of water and Omega-3 fatty acids (fish oil), which provide bone and muscle protection against space radiation.
In the end, the researchers found that customizable drinks with a variety of sweetness levels and flavors are the best options. Going forward, the researchers aspire to test the tastiness of the beverages under microgravity conditions, as they note the drinks taste like typical flat sodas after carbonation loss.
A cancer drug called saracatinib just switched failing brain synapses back on in Alzheimer’s mice — memory returned with them
When researchers at Yale gave a shelved cancer drug to old mice whose brains were already riddled with Alzheimer’s-like damage, the animals started remembering again. Synapses that had gone quiet flickered back to life. Proteins that mark healthy brain connections climbed toward normal levels. And when the drug was taken away, the cognitive gains stuck.
The drug is saracatinib, originally developed by AstraZeneca under the code name AZD0530 to treat solid tumors. It never panned out for cancer. But a team led by Stephen Bhatt and Christopher van Dyck at Yale School of Medicine recognized that its molecular target, an enzyme called Fyn kinase, plays a central role in how amyloid-beta destroys synapses in Alzheimer’s disease. Their work, published across several peer-reviewed studies between 2015 and 2020, has made saracatinib one of the more closely watched examples of drug repurposing in neuroscience. As of mid-2026, the compound’s preclinical results remain striking, but its clinical story is more complicated.
Mechanical load inhibits cancer growth in mouse and human hearts
The heart’s constant beating may actively suppress tumor growth in cardiac tissues, a new Science study reports. This is because cellular pathways in these tissues alter gene regulation in cancer cells to keep them from proliferating.
The findings shed light on the role of mechanical forces in protecting the heart from cancer and may pave the way to new cancer therapies based on mechanical stimulation.
The heart rarely develops cancer, and, at the same time, it lacks regenerative capacity, as cardiomyocytes stop proliferating after birth. This suggests that mechanisms limiting cardiac regeneration may also protect against cancer. In this work, we investigated the role of mechanical load and used in vivo cancer models and ex vivo engineered heart tissues to show that mechanical load reduces cancer cell proliferation in the myocardium. Spatial transcriptomics of human cardiac metastases revealed decreased histone methylation and chromatin compaction. These changes affect chromatin accessibility at proliferation-related loci, with Nesprin-2 identified as a key mechanosensor. Our results uncover how mechanical forces protect the heart from cancer and suggest potential strategies for cancer therapy based on mechanical stimulation.